A Proteomics Approach to Identifying Key Protein Targets Involved in VEGF Inhibitor Mediated Attenuation of Bleomycin-Induced Pulmonary Fibrosis

Proteomics - Germany
doi 10.1002/pmic.201500171
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

MnTBAP Inhibits Bleomycin-Induced Pulmonary Fibrosis by Regulating VEGF and WNT Signaling

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2016English

High Endogenous Activated Protein C Levels Attenuates Bleomycin-Induced Pulmonary Fibrosis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2016English

Glycyrrhizic Acid Alleviates Bleomycin-Induced Pulmonary Fibrosis in Rats

Frontiers in Pharmacology
Pharmacology
2015English

Enhancing Natriuretic Peptide Bioactivity Prevents Bleomycin-Induced Pulmonary Fibrosis

BMC Pharmacology
2011English

Prostaglandin D2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis

PLoS ONE
Multidisciplinary
2016English

Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Attenuates Bleomycin-Induced Lung Fibrosis

American Journal of Pathology
Forensic MedicinePathology
2006English

E- And P-Selectins Synergistically Inhibit Bleomycin-Induced Pulmonary Fibrosis

American Journal of Pathology
Forensic MedicinePathology
2006English

Role of Histamine H 4 Receptor Ligands in Bleomycin-Induced Pulmonary Fibrosis

Pharmacological Research
Pharmacology
2016English

Prevention of Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice by Paeonol

Frontiers in Physiology
Physiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy